Canaccord Adams maintains a 'Buy' on Vascular Solutions (Nasdaq: VASC), raises price target to $11.

Canaccord analyst says, "We see ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE